Company Profile
Gritstone Oncology
Company Overview
Gritstone Oncology is a fast-growing, innovative biotechnology company developing the next generation of personalized cancer immunotherapies. Gritstone brings together distinguished scientific founders, an experienced and diverse management team, a seasoned and successful board of directors, and very deep financial backing to tackle fundamental challenges at the intersection of cancer biology, immunology and immunotherapy design. The goal is to develop breakthrough immunotherapy treatments for patients with cancer by identifying and deploying neoantigens from each patient’s tumor to develop personalized cancer vaccines. Gritstone Oncology is headquartered in the San Francisco Bay Area with certain key functions located in Pleasanton, CA and Cambridge, MA.
Notable Accomplishments / Recognition
Gritstone Oncology is headquartered in Emeryville, California, with key functions located in Cambridge, Massachusetts and Pleasanton, California. We were founded in August 2015 and are listed on the Nasdaq Global Select Market under the ticker symbol GRTS.